Detecting very early liver cancer and tracking its natural course
Part of Cancer, Digestive system clinical trials.
This study looks at how well doctors can detect small, early liver cancer and then follow how it changes over time. It may help your care team choose the best next steps based on earlier, clearer detection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can understand the study and sign informed consent
- You are 18 years or older
- You have been diagnosed with small early liver cancer (either with cirrhosis but well-functioning liver, or without cirrhosis)
- Your liver cancer diagnosis was shown or confirmed within 3 months of the first study visit
- If you do NOT have cirrhosis, the diagnosis must be confirmed by a tissue sample (biopsy), not only scans
- You have not had certain liver cancer treatments in the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with cirrhosis to see how best to detect liver cancer early. If you qualify, you may receive regular monitoring that could help find liver cancer sooner, when treatment is more likely to work.
This trial tests a new blood test to help detect liver cancer (HCC) or confirm it’s not present in people with cirrhosis who are being monitored. It may help improve how doctors screen for liver cancer and decide who needs further imaging or treatment.
This study checks whether a blood test (circulating tumor DNA) can help predict if hepatocellular carcinoma (HCC) will return after curative treatment like surgery or ablation. If it works, it may help doctors plan closer follow-up or earlier treatment if recurrence risk is higher.
This trial is testing if a blood test can find liver cancer early. It may help people who are newly diagnosed or suspected to have liver cancer and have not started treatment yet.
This trial is testing a routine screening program for liver cancer (hepatocellular carcinoma) in people who are at higher risk of developing it. The goal is to catch cancer early, when treatment works best.
This study is looking for people with or without liver cancer to test a new way to find liver cancer early using blood or tissue samples. It aims to help catch the disease sooner.
Hear when a new Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.